Nuclear Matrix and Steroid Hormone Action

Vitamins and Hormones

Volumn 55, Issue C, 1998, Pages 127-163

  Barrett, Thomas J ^a   Spelsberg, Thomas C ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GESTAGEN; GROWTH HORMONE RECEPTOR; HIGH MOBILITY GROUP PROTEIN; INTERFERON; PROGESTERONE RECEPTOR; VITAMIN D;

ANIMAL; APOPTOSIS; BIRD; BREAST TUMOR; CELL NUCLEUS MATRIX; CHEMISTRY; CHROMATIN; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; BIRDS; BREAST NEOPLASMS; CHROMATIN; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; INTERFERONS; NUCLEAR MATRIX; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, SOMATOTROPIN; VITAMIN D;

EID: 0032608965     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60935-8     Document Type: Article

References (222)

1. 3: Direct inhibition of NFAT p-AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15 (1995) 5789-5799
2. Alvarez M., Long H., Onyia J., Hock J., Xu W., and Bidwell J. Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology (Baltimore 138 (1997) 482-489
3. Archer T.K., Cordingley M.G., Wolford R.G., and Hager G.L. Transcription factor accesses mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol. Cell. Biol. 11 (1991) 688-698
4. Attal J., Cajero-Juarez M., Petitclerc D., Theron M.-C., Stinnakre M.-G., Bearzotti M., Kann G., and Houdebine L.-M. The effect of matrix attached regions (MAR) and specialized chromatin structure (SCS) on the expression of gene constructs in cultured cells and in transgenic mice. Mol. Biol. Rep. 22 (1996) 37-46
5. Banerjee C., Stein J.L., van Wijnen A.J., Frenkel B., Lian J.B., and Stein G.S. Transforming growth factor-beta 1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology (Baltimore 137 (1996) 1991-2000
6. Baniahmad C., Nawaz Z., Baniahmad A., Gleeson M.A.G., Tsai J.J., and O'Malley B.W. Enhancement of human estrogen receptor activity by SPT6: A potential co-activator. Mol. Endocrinol. 9 (1995) 34-43
7. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyl-transferase. Nature (London 384 (1996) 641-643
8. Barrett T.J., Tomlinson A.J., Benson L.M., Sandhu N.P., Subramanian M., Naylor S., and Spelsberg T.C. Structure/function analyses of a nuclear matrix-associated steroid receptor binding factor (RBF) and the RBF DNA binding element (1998) Submitted
9. Beato M. Transcriptional regulation of mouse mammary tumor virus by steroid hormones. CRC Crit. Rev. Oncog. 2 (1991) 195-210
10. Beato M., and Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endoc. Rev. 17 (1996) 587-609
11. Beato M., Chavex S., and Truss M. Transcriptional regulation by steroid hormones. Steroids 61 (1996) 240-251
12. Berezney R. Dynamic properties of the nuclear matrix. In: Busch D.H. (Ed). In "The Cell Nucleus" 7 (1979), Academic Press, New York 413-456
13. Berezney R. The nuclear matrix: A heuristic model for investigating genomic organization and function in the cell nucleus. J. Cell Biochem. 40 (1991) 109-123
14. Berezney R., and Coffey D. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun. 60 (1974) 1410-1419
15. Berezney R., and Coffey D.S. Nuclear protein matrix: Association with newly synthesized DNA. Science 189 (1975) 291-293
16. Berezney R., and Coffey D.S. The nuclear protein matrix: Isolation, structure and function. Adv. Enzyme Regul. 14 (1976) 63-100
17. Berezney R., and Coffey D.S. Nuclear matrix: Isolation and characterization of a framework structure from rat liver nuclei. J. Cell Biol. 73 (1977) 616-637
18. In: Berezney R., and Jeon K.W. (Eds). International Review of Cytology/Cell Biology (1995), Academic Press, San Diego, CA
19. Berg J.N., van Opheusden J.H.J., Burgering M.J.M., Boelens R., and Kaptein R. Structure of Arc repressor in solution: Evidence for a family of β-sheet DNA-binding proteins. Nature (London 346 (1990) 586-589
20. Bergemann A.D., Ma Z.-W., and Johnson E.M. Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Mol. Cell. Biol. 12 (1992) 5673-5682
21. Berges R., Furuya Y., Remington L., English H.F., Jacks T., and Isaacs J.T. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8910-8914
22. Bidwell J.P., van Wijnen A.J., Fey E.G., Dworetzky S., Penman S., Stein J.L., Lian J.B., and Stein T.S. Osteocalcin gene promoter binding factors are tissue-specific nuclear matrix components. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3162-3166
23. Bidwell J.P., Fey E.G., van Wijnen A.J., Penman S., Stein J.L., Lian J.B., and Stein G.S. Nuclear matrix proteins distinguish normal diploid osteoblasts from osteocarcoma cells. Cancer Res. 54 (1994) 28-32
24. Bode J., Schlake T., Rios-Ramirez M., Mielke C., Stengert M., Kay V., and Klehr-Wirth D. Scaffold/matrix-attached regions: Structural properties creating transcriptionally active loci. Int. Rev. Cytol. 162A (1995) 389-454
25. Bode J., Stengert-Iber M., Kay V., Schlake T., and Dietz-Pfeilstetter A. Scaffold/matrix-attached regions: Topological switches with multiple regulatory functions. Crit. Rev. Eukaryotic Gene Expression 6 (1996) 115-138
26. Boudreau N., Myers C., and Bissell M.J. From laminin to lamin: Regulation of tissue-specific gene expression by the ECM. Trends Cell Biol. 5 (1995) 1-4
27. Breen E.C., van Wijnen A.J., Lian J.B., Stein G.S., and Stein J.L. In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D dependent transcriptional upregulation in intact cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12902-12906
28. Burch J.B.E., and Evans M.I. Chromatin structural transitions and the phenomenon of vitellogenin gene memory in chickens. Mol. Cell. Biol. 6 (1986) 1886-1893
29. Burch J.B.E., and Weintraub H. Temporal order of chromatin structure changes associated with activation of the major chicken vitellogenin gene. Cell (Cambridge, Mass. 33 (1983) 65-76
30. Buttyan R., Olsson C.A., Pintar J., Chang C., Bandyk M., Ng P.-Y., and Sawczuk I.S. Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol. Cell. Biol. 9 (1989) 3473-3481
31. Candau R., Chavez S., and Beato M. The hormone responsive region of mouse mammary tumor virus positions a nucleosome and precludes access of nuclear factor I to the promoter. J. Steroid Biochem. Mol. Biol. 57 (1996) 19-31
32. Cantorna M.T., Nashold F.E., Chun T.Y., and Hayes C.E. Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J. Immunol. 156 (1996) 2674-2679
33. Capitani S., Girard P.R., Mazzeli G.J., Kuo J.F., Berezney R., and Manzoli F.A. Immunochemical characterization of protein kinase C in rat liver nuclei and subnuclear fractions. Biochem. Biophys. Res. Commun. 142 (1987) 367-375
34. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P.J., and Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14 (1995) 3741-3751
35. Chávez S., Candau R., Truss M., and Beato M. Constitutive repression and nuclear factor I-dependent hormone activation of the mouse mammary tumor virus promoter in Saccharomyces cerevisiae. Mol. Cell. Biol. 15 (1995) 6987-6998
36. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., and Evans R.M. Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (Cambridge, Mass. 90 (1997) 569-580
37. Cippitelli M., Sica A., Viggiano V., Ye J., Ghosh P., Birrer M.J., and Young H.A. Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-jun. J. Biol. Chem. 270 (1995) 12548-12556
38. Codina-Salada J., Moore J.P., and Chan L. Kinetics of primary and secondary stimulation of the mRNA for apoVLDL-II, a major yolk protein, in the cockerel liver by estrogen. Endocrinology (Baltimore 113 (1983) 1158-1160
39. Cordingley M.G., Riegel A.T., and Hager G.L. teroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell (Cambridge, Mass. 48 (1987) 261-270
40. Coutts A.S., Davie J.R., Dotzlaw H., and Murphy L.C. Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J. Cell. Biochem. 63 (1996) 174-184
41. Cullen K.E., Kladde M.P., and Seyfred M.A. Interaction between transcription regulatory regions of prolactin chromatin. Science 261 (1993) 203-206
42. Davie J.R. Histone modifications, chromatin structure, and the nuclear matrix. J. Cell. Biochem. 62 (1996) 149-157
43. Davie J.R. Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol. Biol. Rep. 24 (1997) 197-207
44. Deeley R.G., Udell D.S., Burns A.T.H., Gordon J.I., and Goldberger R.F. Kinetics of avian vitellogenin messenger RNA induction. Comparison between primary and secondary response to estrogen. J. Biol. Chem. 252 (1977) 7913-7915
45. de-Thé H., Lavau C., Marchio A., Chomienne C., Degos L., and Dejean A. The PML/RARα fusion mRNA generated by the t(15;17) translocation of acute promyelocytic leukemia encodes a functionally altered RAR. Cell (Cambridge, Mass. 76 (1991) 333-343
46. Dickinson P., Cook P.R., and Jackson D.A. Active RNA polymerase I is fixed within the nucleus of HeLa cells. EMBO J. 9 (1990) 2207-2214
47. Djabali K., Portier M.-M., Gros F., Biobel G., and Georgatos S.D. Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments. Cell (Cambridge, Mass. 64 (1991) 109-121
48. Donat T.L., Sakr W., Lehn J.E., and Pienta K.J. Nuclear matrix protein alteration in intermediate biomarkers in squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg. 114 (1996) 387-393
49. Du W., Thanos D., and Maniatis T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell (Cambridge, Mass. 74 (1993) 887-898
50. Dunn D.K., Whelan R.D., Hill B., and King R.J. Relationship of hsp27 and oestrogen receptor in hormone sensitive and insensitive cell lines. J. Steroid Biochem. Mol. Biol. 46 (1993) 469-479
51. Durfee T., Mancini M.A., Jones D., Elledge S.J., and Lee W.H. The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J. Cell. Biochem. 127 (1994) 609-622
52. Dworetzky S.I., Fey E.G., Penman S., Lian J.B., Stein J.L., and Stein G.S. Progressive changes in the protein composition of nuclear matrix during rat osteoblast differentiation. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4605-4609
53. Edinger R.S., Mambo E., and Evans M.I. Estrogen-dependent transcriptional activation and vitellogenin gene memory. Mol. Endocrinol. 11 (1997) 1985-1993
54. Elbrecht A., Lazier C.B., Protter A.A., and Williams D.L. Independent development programs for two estrogen-regulated genes. Science 255 (1984) 639-641
55. English H.F., Kyprianou N., and Isaacs J.T. Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15 (1989) 233-250
56. cmyc as a member of a discrete subset of nuclear protein. Cell (Cambridge, Mass. 43 (1985) 253-261
57. Evans E.I., O'Malley P.J., Krust A., and Burch J.B.E. Developmental regulation of the estrogen receptor and the estrogen responsiveness of five yolk protein genes in the avian liver. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 8493-8497
58. Evans M.I., Silva R., and Burch J.B.E. Isolation of chicken vitellogenin I and III cDNAs and the developmental regulation of five estrogen-responsive genes in the embryonic liver. Genes Dev. 2 (1988) 116-124
59. Fanjul A.N., Bouterfa H., Dawson M., and Pfahl M. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res. 56 (1996) 1571-1577
60. Feuerstein N., and Randazzo P.A. In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. Exp. Cell Res. 194 (1991) 289-296
61. Fey E.G., and Penman S. Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 121-125
62. Fink K.L., Wieben E.D., Woloschak G.E., and Spelsberg T.C. Rapid regulation of c-myc proto-oncogene expression by progesterone in the avian oviduct. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1796-1800
63. Fritton H.P., Sippel A.E., and Igo-Kemenes T. Nuclease-hypersensitive sites in the chromatin domain of the chicken lysozyme gene. Nucleic Acids Res. 11 (1983) 3467-3485
64. Gasser S.M., and Laemmli U.K. The organization of chromatin loops: Characterization of a scaffold attachment site. EMBO J. 5 (1986) 511-518
65. Georgatos S.D., and Blobel G. Lamin B constitutes an intermediate filament attachment site at the nuclear envelope. J. Cell Biol. 105 (1987) 117-125
66. Getzenberg R.H. Nuclear matrix and the regulation of gene expression: Tissue specificity. J. Cell. Biochem. 55 (1994) 22-31
67. Getzenberg R.H., Pienta K.J., Huang E.Y., and Coffey D.S. Identification of nuclear matrix proteins in the cancer and normal prostate. Cancer Res. 51 (1991) 6514-6520
68. Getzenberg R.H., Konety B.R., Oeler T.A., Quigley M.M., Hakam A., Becich M.J., and Bahnson B.R. Bladder cancer associated nuclear matrix proteins. Cancer Res. 56 (1996) 1690-1694
69. Giancotti V., Bandiera A., Sindici C., Perissin L., and Crane-Robinson C. Calcium-dependent ADP-ribosylation of high-mobility-group I (HMGI) proteins. Biochem. J. 317 (1996) 865-870
70. Goldberger A., and Spelsberg T.C. Partial purification and preparation of polyclonal antibodies against the chromatin acceptor proteins for the avian oviduct progesterone receptor. Biochemistry 27 (1988) 2103-2109
71. Gongora C., David G., Pintard L., Tissot C., Hua T.D., Dejean A., and Mechti N. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272 (1997) 19457-19463
72. Grotzinger T., Sternsdorf T., Jensen K., and Will H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J. Biochem. 238 (1996) 554-560
73. Guiochon-Mantel A., Delabre K., Lescop P., and Milgrom E. Intracellular traffic of steroid hormone receptors. J. Steroid Biochem. Mol. Biol. 56 (1996) 3-9
74. Guo B., Odgren P.R., van Wijnen A.J., Last T.J., Nickerson J., Penman S., Lian J.B., Stein J.L., and Stein G.S. The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10526-10530
75. Hendzel M.J., Delcuve B.P., and Davie J.R. Histone deacetylase is a component of the internal nuclear matrix. J. Biol. Chem. 266 (1991) 21936-21942
76. Henttu P.M., Kalkhoven E., and Parker M.G. AF-2 activity and recruitment of steroid receptor co-activator 1 to the estrogen receptor depend on a lysine conseryed in nuclear receptors. Mol. Cell. Biol. 17 (1997) 1832-1839
77. Hernandez-Verdun D., and Gautier T. The chromosome periphery during mitosis. BioEssays 16 (1994) 179-185
78. Hong H., Kohli K., Garabedian M.J., and Stallcup M.R. GRIP1, a transcriptional co-activator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17 (1997) 2735-2744
79. Hora J., Horton M.J., Toft D.O., and Spelsberg T.C. Nuclease resistance and the enrichment of native nuclear acceptor sites for the avian oviduct progesterone receptor. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8839-8843
80. Hsu H.-L., and Yeh N.-H. Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis. J. Cell Sci. 109 (1996) 277-288
81. Iacopino F., Robustelli D.C.G., and Sica G. Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast cancer cell lines. Int. J. Cancer 71 (1997) 1103-1108
82. Jantzen C., Fritton H.P., and Igo-Kemenes T. Partial overlapping of binding sequences for steroid hormone receptors and DNaseI hypersensitive sites in the rabbit uteroglobin gene region. Nucleic Acids Res. 15 (1987) 4525-4552
83. Jensen E.V. Overview of the nuclear receptor family. In: Parker M.G. (Ed). In "Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions, Clinical Abnormalities" (1991), Academic Press, San Diego, CA 1-14
84. Jost J.-P., Ohno T., Panyim S., and Schuerch A.R. Appearance of vitellogenin sequences and rate of vitellogenin synthesis in chicken liver following primary and secondary stimulation by 17β-estradiol. Eur. J. Biochem. 84 (1978) 355-361
85. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., and Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (Cambridge, Mass. 85 (1996) 403-414
86. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., and Poirier G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53 (1993) 3976-3985
87. Keesee S.K., Briggman J.V., Thill G., and Wu Y.-J. Utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukaryotic Gene Expression 6 (1996) 189-214
88. Kerr G.F.R. Shrinkage necrosis: A distinct mode of cellular death. J. Pathol. 105 (1971) 13-20
89. Khavari P.A., Peterson C.L., Tamkun J.W., Mendel D.B., and Crabtree G.R. BRG1 contains a conserved domain of SW12/SNF2 family necessary for normal mitotic growth and transcription. Nature (London 366 (1993) 170-174
90. Kim M.K., Lesoon-Wood L.A., Weintraub B.D., and Chung J.H. A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain. Mol. Cell. Biol. 16 (1996) 4366-4377
91. Kingston R.E., Bunker C.A., and Imbalzano A.N. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev. 10 (1996) 905-920
92. Koken M.H., Linares-Cruz G., Quignon F., Viron A., Chelbi-Aliz M.K., Sobczak-Thepot J., Juhlin L., Degos L., Calvo F., and de-Thé H. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10 (1995) 1315-1324
93. Korioth F., Gieffers C., Maul G.G., and Frey J. Molecular characterization of a DNP52, a novel protein of the nuclear domain 10, which is redistributed upon virus injection and interferon treatment. J. Cell. Biochem. 130 (1995) 1-13
94. Kwon H., Imbalzano A.N., Khavari P.A., Kingston R.E., and Green M.R. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature (London 370 (1994) 477-481
95. Kyprianou N., English H.F., and Isaacs J.T. Activation of a CA2+-MG2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 13 (1988) 103-117
96. LaCasse E.C., Lochnan H.A., Walker P., and Lefebvre Y.A. Identification of binding proteins for nuclear localization signals of the glucocorticoid and thyroid hormone receptors. Endocrinology (Baltimore 132 (1993) 1017-1025
97. Laemmli U.K., Kas E., Poljak L., and Adachi Y. Scaffold-associated regions: Cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev. 2 (1992) 275-285
98. Landers J.P., and Spelsberg T.C. Updates and new models for steroid hormone action. Ann. N.Y. Acad. Sci. 637 (1991) 26-55
99. Landers J.P., and Spelsberg T.C. New concepts in steroid hormone action: Transcription factors, proto-oncogenes and the cascade model for steroid regulation of gene expression. Crit. Rev. Eukaryotic Gene Expression 2 (1992) 19-63
100. Lauber A.H., Sandhu N.P., Schuchard M., Subramaniam M., and Spelsberg T.C. Nuclear matrix acceptor binding sites for steroid hormone receptors: A candidate nuclear matrix acceptor protein. In: Berezney R., and Jeon K.W. (Eds). In "International Review of Cytology/Cell Biology" (1995), Academic Press, San Diego, CA 337-376
101. Lauber A.H., Barrett T.J., Subramaniam M., Schuchard M., and Spelsberg T.C. A DNA binding element for a steroid receptor binding factor is flanked by dual nuclear matrix attachment sites in the c-myc gene promoter. J. Biol. Chem. 272 (1997) 24657-24665
102. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., and Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371 (1994) 346-347
103. Lazebnik Y.A., Takahashi A., Moir R.D., Goldman R.D., Poirier G.G., Kaufmann S.H., and Earnshaw W.C. Studies of the lamin proteinases reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9042-9046
104. Lazebnik Y.A., Takahashi A., Poirier G.G., Kaufmann S.H., and Earnshaw W.C. Characterization of the execution phase of apoptosis in vitro using extracts from condemned-phase cells. J. Cell Sci. Suppl. 19 (1995) 41-49
105. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., and Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature (London 374 (1995) 91-94
106. Lemieux P., Lawrence J., Steeg P., Oesterreich S., and Fuqua S.A.W. Transfection of hsp27 overexpression affects growth and motility of an estrogen receptor negative human breast cancer cell line. Proc. Am. Assoc. Cancer Res. 37 (1996) 68
107. Lewis C.D., Lebkowski J.S., Daly A.K., and Laemmli U.K. Interphase nuclear matrix and metaphase scaffolding structures. J. Cell Sci., Suppl. 1 (1984) 103-122
108. Lin H.Y., Thacore H.R., Davis F.B., and Davis P.J. Thyroid hormone analogues potentiate the antiviral action of interferon-gamma by two mechanisms. J. Cell. Physiol. 167 (1996) 269-276
109. Lindenmuth D.M., van Wijnen A.J., Hiebert S., Stein J.L., Lian J.B., and Stein G.S. Subcellular partitioning of transcription factors during osteoblast differentiation: Developmental association of the AML/CBFα/PEBP2α-related transcription factor-NMP-2 with the nuclear matrix. J. Cell. Biochem. 66 (1997) 123-132
110. Lindner D.J., Kolla V., Kalvakolanu D.V., and Borden E.C. Tamoxifen enhances interferon-regulated gene expression in breast cancer cells. Mol. Cell. Biochem. 167 (1997) 1997
111. Liu J.H., Mu Z.M., and Chang K.S. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181 (1995) 1965-1973
112. Luderus M.E.E., den Blaauwen J.L., de Smit O.J.B., Compton D.A., and van Driel R. Binding of matrix attachment regions to lamin polymers involves single-stranded regions and the minor groove. Mol. Cell. Biol. 14 (1994) 6297-6305
113. Lydersen B.K., and Pettijohn D.E. Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell. Cell (Cambridge, Mass. 22 (1980) 489-499
114. Mainwaring W.I.P., and Derry N.S. Enhanced transcription of rRNA genes by purified androgen receptor complexes. in vitro. J. Steroid Biochem. 19 (1983) 101-108
115. Mainwaring W.I.P., and Wilce P.A. The control of the form and function of the ribosomes in androgen-dependent tissues by testosterone. Biochem. J. 134 (1973) 795-805
116. Mancini M.A., Shan B., Nickerson J.A., Penman S., and Lee W.-H. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated proteins. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 418-422
117. Martelli A.M., Cocco L., Riederer B.M., and Neri L.M. The nuclear matrix: A critical appraisal. Histol. Histopathol. 11 (1996) 1035-1048
118. McCaffery J.D., Gapany M., Faust R.A., Davis A.T., Adams G.L., and Ahmed K. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck. Arch. Otolaryngol Head Neck Surg. 123 (1997) 283-288
119. Merriman H.L., van Wijnen A.J., Hiebert S., Bidwell J.P., Fey E., Lian J., Stein S., and Stein G.S. The tissue-specific nuclear matrix, NMP-2, is a member of the AML/CBF/PEBP2/Runt domain transcription factor family: Interactions with the osteocalcin gene promoter. Biochemistry 34 (1995) 13125-13132
120. Miller T.E., Beausang L.A., Meneghini M., and Lidgard G. Cell death and nuclear matrix proteins. In: Tomei L.D., and Cope F.O. (Eds). In "Apoptosis II: The Molecular Basis of Apoptosis in Disease" (1994), Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY 357-376
121. Montecino M., Pockwinse S., Lian J.B., Stein G.S., and Stein J.L. DNase/hypersensitive sites in promoter elements associated with basal and vitamin D dependent transcription of the bone-specific osteocalcin gene. Biochemistry 33 (1994) 348-353
122. Montecino M., Lian J.B., Stein G.S., and Stein J.L. Changes in chromatin structure support constitutive and developmentally regulated transcription of the bone-specific osteocalcin gene in osteoblastic cells. Biochemistry 35 (1996) 5093-5102
123. Moretti-Rojas I., Fuqua S.A.W., Montgomery R.A.I., and McGuire W.L. A cDNA for the estradiol-regulated 24 K protein: Control of mRNA levels in MCF-7 cells. Breast Cancer Res. Treat. 11 (1988) 155-163
124. Mu Z.M., Chin K.V., Liu J.H., Lozano G., and Chang K.S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol 14 (1994) 6858-6867
125. Muchardt C., and Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SW12 and Drosophila-brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12 (1993) 4279-4290
126. Mulder J.R., Offerhaus J.A., de Feyter E.P., Floyd J.J., Kern S.E., Vogelstein B., and Hamilton S.R. The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Am. J. Pathol. 141 (1992) 797-804
127. Nakayasu H., and Berezney R. Nuclear matrix: Identification of the major nuclear matrix proteins. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10312-10316
128. Nardozza T.A., Quigley M.M., and Getzenberg R.H. Association of transcription factors with the nuclear matrix. J. Cell. Biochem. 61 (1996) 467-477
129. 1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J. Immunol. 154 (1995) 3788-3795
130. Nielsen K., Orntoft T., and Wolf H. Sterologic estimates of nuclear volume in noninvasive bladder tumors (Ta) correlated with the recurrence pattern. Cancer (Philadelphia 64 (1989) 2269-2274
131. Nitsch D., Steward A.F., Boshart M., Mestril R., Weih F., and Schütz G. Chromatin structure of the rat tyrosine aminotransferase gene relate to the function if its cis-acting elements. Mol. Cell. Biol. 10 (1990) 3334-3342
132. Noon Y.S., Kim J.W., Wang K.W., Kim Y.S., Choi K.H., and Joe C.O. Poly (ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis. J. Biol. Chem. 271 (1996) 9129-9134
133. Norbiato G., Bevilacqua M., Vago T., and Clerici M. Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 81 (1996) 2601-2606
134. Oberhammer F.A., Hochegger K., Froschl G., Tiefenbacher R., and Pavelka M. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J. Cell Biol. 126 (1994) 827-837
135. 3 in monocytic U937 cells. Biochim. Biophys. Acta 1269 (1995) 25-31
136. Oesterreich S., Weng C.-N., Qui M., Hilsenbeck S.G., Osborne C.K., and Fuqua S.A.W. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 53 (1993) 4443-4448
137. Oesterreich S., Hickey E., Weber L., and Fuqua S.A.W. Basal regulatory elements of the hsp27 promoter in human breast cancer cell lines. Biochem. Biophys. Res. Commun. 222 (1996) 155-163
138. Oesterreich S., Hilsenbeck S.G., Allred D.C., Ciocca D., Chamness G.C., Osborne C.K., and Fuqua S.A.W. The small heat shock protein hsp27 is not an independent prognostic marker in auxillary lymph node-negative breast cancer patients. Clin. Cancer Res. 2 (1996) 1199-1206
139. Oesterreich S., Lee A.V., Sullivan T.M., Samuel S.K., Davie J.R., and Fuqua S.A.W. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. J. Cell. Biochem. 67 (1997) 275-286
140. Ogryzki V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional co-activators p300 and CBP are histone acetyltransferases. Cell (Cambridge, Mass. 87 (1996) 953-959
141. Onate S.A., Prendergast P., Wagner J.P., Nissen M., Reeves R., Pettijohn D.E., and Edwards D.P. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol. Cell. Biol. 14 (1994) 3376-3391
142. Partin A.W., Getzenberg R.H., CarMichael M.J., Vindivich D., Yoo J., Epstein J.I., and Coffey D.S. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res. 53 (1993) 744-746
143. Paull T.T., Haykinson M.J., and Johnson R.C. The nonspecific DNA-binding and bending proteins HMG1 and HMG2 promote the assembly of complex nucleo-protein structures. Genes Dev. 7 (1993) 1521-1534
144. Perlmann T., and Wrange O. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7 (1988) 3073-3079
145. Peterson C.L. Multiple switches to turn on chromatin. Curr. Opin. Genet. Dev. 6 (1996) 171-175
146. Pienta K.J., and Coffey D.S. Correlation of nuclear morphometry with progression of breast cancer. Cancer (Philadelphia 68 (1991) 2012-2016
147. Pienta K.J., and Coffey D.S. Nuclear-cytoskeletal interactions: Evidence for physical connections between the nucleus and cell periphery and their alteration by transformation. J. Cell. Biochem. 49 (1992) 357-365
148. Pina B., Truss M., Ohlenbusch H., Postma J., and Beato M. DNA rotational positioning in a regulatory nucleosome is determined by base sequence. An algorithm to model the preferred superhelix. Nucleic Acids Res. 18 (1990) 6981-6987
149. Porter W., Wang F., Duan R., and Safe S. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol. Endocrinol. 10 (1996) 1371-1378
150. Qian X., Jeon C., Yoon H., Agarwal K., and Weiss M.A. Structure of a new nucleic-acid-binding motif in eukaryotic transcriptional elongation factor TFIIS. Nature (London 365 (1993) 277-279
151. Raunmann B.E., Rould M.A., Pabo C.O., and Sauer R.T. DNA recognition by β-sheets in the Arc repressor-operator crystal structure. Nature (London 367 (1994) 754-757
152. Razin S.V. Functional architecture of chromosomal DNA domains. Clin. Rev. Gene Expression 6 (1996) 247-269
153. Razin S.V., and Gromova I.I. The channels model of the nuclear matrix structure. BioEssays 17 (1995) 443-450
154. Rejman J., Landers J.P., Goldberger A., McCormick D., Gosse B., and Spelsberg T.C. Purification of a nuclear protein (Receptor Binding Factor-1) associated with the chromatin acceptor sites for the avian oviduct progesterone receptor. J. Protein Chem. 10 (1991) 651-667
155. Reyes J.C., Muchardt C., and Yaniv M. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell. Biochem. 137 (1997) 263-274
156. Richard-Foy H., and Hager G.L. Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 6 (1987) 2321-2328
157. Romanini M.G.M., and Fraschini A. Facts and paradoxes in current notions of nuclear organization and function. Histol. Histopathol. 11 (1996) 513-519
158. Rories C., and Spelsberg T.C. Ovarian steroid action on gene expression: Mechanisms and models. Annu. Rev. Physiol. 51 (1989) 653-681
159. Ruh M.F., Dunn R., and Ruh T.S. Interrelationships between nuclear structure and ligand-activated intracellular receptors. Crit. Rev. Eukaryotic Gene Expression 6 (1966) 271-283
160. Schild C., Claret F.-X., Wahli W., and Wolffe A.P. A nucleosome-dependenstatic loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter. in vitro. EMBO.J. 12 (1993) 423-433
161. Schuchard M., Rejman J.J., McCormick D.J., Gosse B., Ruesink T., and Spelsberg T.C. Characterization of a purified chromatin acceptor protein (receptor binding factor-1) for the avian oviduct progesterone receptor. Biochemistry 30 (1991) 4535-4542
162. Schuchard M., Subramaniam M., Ruesink T., and Spelsberg T.C. Nuclear matrix localization and specific matrix DNA binding by receptor binding factor-1 of the avian oviduct progesterone receptor. Biochemistry 30 (1991) 9516-9522
163. Schuchard M., Landers J.P., Punkay-Sandhu N., and Spelsberg T.C. Steroid hormone regulation of nuclear proto-oncogenes. Endocr. Rev. 14 (1993) 659-669
164. Sen G.C., and Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267 (1992) 5017-5020
165. Sen G.C., and Ransohoff R.M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42 (1993) 57-102
166. Seymor L., Bezwoda R., Meyer K., and Behr C. Detection of p24 protein in human breast cancer: Influence of receptor status and oestrogen exposure. Br. J. Cancer 61 (1990) 886-890
167. Sica G., Iacopino F., and Recchia F. Interferon and hormone sensitivity of endocrine-related tumors. Anti-Cancer Drugs 7 (1996) 150-160
168. Singh P., Coe J., and Hong W.J. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature (London 374 (1995) 562-565
169. Smith H.C., and Berezney R. Nuclear matrix-bound deoxyribonucleic acid synthesis: An in vitro system. Biochemistry 21 (1982) 6751-6761
170. Smith H.C., and Berezney R. Dynamic domains of DNA polymerase α in regenerating rat liver. Biochemistry 22 (1983) 3042-3046
171. Smith B., and Berman B. Characterization of a glucocorticoid-induced inhibitor of interferon-gamma induction of HLA-DR expression. J. Invest. Dermatol. 99 (1992) 35-39
172. Smith H.C., Harris S.G., Zillmann M., and Berget S.M. Evidence that a nuclear matrix protein participates in premessenger RNA splicing. Exp. Cell Res. 182 (1989) 521-533
173. Somers W.S., and Phillips S.E.V. Crystal structure of the met repressor-operator complex at 2.8 Å resolution reveals DNA recognition by β-strands. Nature (London 359 (1992) 387-393
174. Sorensen F.B., Kristensen I.B., Grymer F., and Jakobsen A. DNA-level, tumor thickness, and sterological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact. Am. J. Dermatopathol. 13 (1991) 11-19
175. Sorensen F.B., Bichel P., and Jakobsen A. DNA level and stereologic estimates of nuclear volume in squamous cell carcinoma of the uterine cervix. Cancer (Philadelphia 69 (1992) 187-199
176. Soury B., Hentzen D., Vignal M., Christeff N., and Doly J. Induction of interferon-beta gene expression by dexamethasone in murine L929 cells. Mol. Endocrinol. 9 (1995) 199-207
177. Spelsberg T.C., Webster R.A., and Pikler G.M. Chromosomal proteins regulate steroid binding to chromatin. Nature (London 262 (1976) 65-67
178. Spelsberg T.C., Littlefield B.A., Seelke R., Martin-Dani G., Toyoda H., Boyd-Leinen P., Thrall C., and Kon O.L. Role of specific chromosomal proteins and DNA sequences in the nuclear binding sites for steroid receptors. Recent Prog. Horm. Res. 39 (1983) 463-517
179. Spelsberg T.C., Gosse B.J., Littlefield B.A., Toyoda H., and Seelke R. Reconstitution of native-like nuclear acceptor sites of the avian oviduct progesterone receptor: Evidence for involvement of specific chromatin proteins and specific DNA sequences. Biochemistry 23 (1984) 5103-5113
180. Spelsberg T.C., Hora J., Horton M., Goldberger A., Littlefield B., Seelke R., and Toyoda H. Specific DNA binding proteins and DNA sequences involved in steroid hormone regulation of gene expression. In: Thompson E.G., and Papaconstantinous J. (Eds). In "DNA: Protein Interactions and Gene Regulation" (1987), University of Texas Press, Austin 259-267
181. Spelsberg T.C., Horton M., Fink K., Goldberger A., Rories C., Gosse B., and Rasmussen K. A new model for steroid regulation of gene transcription using chromatin acceptor sites and regulatory genes and their products. In: Moudgil V.K. (Ed). In "Recent Advances in Steroid Hormone Action" (1987), de Gruyter, Berlin and New York 31-48
182. Spelsberg T.C., Rories C., Rejman J., Goldberger A., Fink K., Lau C.K., Colvard D., and Wiseman G. Steroid action on gene expression: Possible roles of regulatory genes and nuclear acceptor sites. Biol. Reprod. 40 (1989) 54-69
183. Spelsberg T.C., Subramaniam M., Harris S.A., Oursler M.J., Schuchard M., Landers J.P., and Sandhu N. Nuclear proto-oncogenes as regulatory genes and as marker genes for steroid action in all target tissues. In: Sahaib K., and Stancel G. (Eds). In "Proto-oncogenes and Growth Factors in Steroid Hormone Induced Growth and Differentiation" (1993), CRC Press, Boca Raton, FL 69-86
184. Spelsberg T.C., Lauber A., Sandhu H., and Subramaniam M. Composition and structure of a nuclear matrix acceptor site for the avian progesterone receptor in c-myc gene promoter. Recent Prog. Horm. Res. 51 (1996) 63-96
185. Spencer T.E., Ing N.H., Ott T.L., Mayes J.S., Becker W.C., Watson G.H., Mirando M.A., and Bazer F.W. Intrauterine injection of ovine interferon tau alters oestrogen receptor and oxytocin receptor expression in the endometrium of cyclic ewes. J. Mol. Endocrinol. 15 (1995) 203-220
186. Stein G.S., Lian J.B., van Wijnen A.J., and Stein J.L. The osteocalcin gene: A model for multiple parameters of skeletal-specific transcriptional control. Mol. Biol. Rep. 24 (1997) 185-196
187. Stelzer G., Goppelt A., Lottspeich F., and Meisterernst M. Repression of basal transcription by HMG2 is counteracted by TFIH-associated factors in an ATP-dependent process. Mol. Cell. Biol. 14 (1994) 4712-4721
188. Streuli C.H., Schmidhauser C., Bailey N., Yurchenco P., Skubitz A.P.N., Roskelley C., and Bissel M.J. Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129 (1995) 591-603
189. Stuurman N., Meijne A.M.L., van der Pol A.J., de Jong L., van Driel R., and van Renswoude J. The nuclear matrix from cells of different origin. Evidence for a common set of matrix proteins. J. Biol. Chem. 265 (1990) 5460-5465
190. Szostecki C., Guldner H.H., Netter N.J., and Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by auto-antibodies from patients with primary biliary cirrhosis. J. Immunol. 145 (1990) 4338-4347
191. Takemura M., Ohta N., Furuichi Y., Takahashi T., Yoshida S., Olson M.O.J., and Umekawa H. Stimulation of calf thymus DNA polymerase alpha activity by nucleolar protein B23. Biochem. Biophys. Res. Commun. 28 (1994) 46-51
192. Tamkun J.W., Deuring R., Scott M.P., Kissinger M., Pattatucci A.M., Kaufman T.C., and Kennison J.A. Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell (Cambridge, Mass. 68 (1992) 561-572
193. Tanaka H., Makino Y., Miura T., Hirano F., Okamoto K., Komura K., Sato Y., and Makino I. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid: Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J. Immunol. 156 (1996) 1601-1608
194. Tandon A.K., Clark G.M., Chamness G.C., Fuqua S.A.W., Welch W.J., Riehl R.M., and McGuire W.L. Heat shock stress response proteins: Biological and clinical significance in breast cancer. Proc. Am. Soc. Clin. Oncol. 9 (1990) 84
195. Tanuma S. Molecular mechanisms of apoptosis. In: Sluyser M. (Ed). In "Apoptosis in Normal Development and Cancer" (1996), Taylor & Francis, Bristol, PA 39-60
196. Tawfic S., and Ahmed K. Association of casein kinase 2 with nuclear matrix. J. Biol. Chem. 269 (1994) 7489-7493
197. Tawfic S., and Ahmed K. Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. Evidence based on androgen action in the prostate. J. Biol. Chem. 269 (1994) 24615-24620
198. Tawfic S., Goueli S., Olson M.O.J., and Ahmed K. Androgenic regulation of the expression and phosphorylation of prostatic nucleolar protein B23. Cell. Mol. Biol. Res. 39 (1993) 43-51
199. Tawfic S., Olson M.O.J., and Ahmed K. Role of protein phosphorylation in post-translational regulation of protein B23 during programmed cell death in the prostate gland. J. Biol. Chem. 270 (1995) 21009-21015
200. Terris B., Baldin V., Dubois S., Degott C., Flejou J.F., Henin D., and Dejean A. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55 (1995) 1590-1597
201. Thrall C.L., and Spelsberg T.C. Factors affecting the binding of chick oviduct progesterone receptor to DNA: Evidence that DNA alone is not the nuclear acceptor site. Biochemistry 19 (1980) 4130-4138
202. Tinnemans M.M.F.J., Lenders M.-J.J.H., ten Velde G.P.M., Ramaekers F.C.S., and Schutte B. Alterations in cytoskeletal and nuclear matrix-associated proteins during apoptosis. Eur. J. Cell Biol. 68 (1995) 35-46
203. Toyoda T., Seelke R., Littlefield B.A., and Spelsberg T.C. Evidence for specific DNA sequences in the nuclear acceptor sites of the avian oviduct progesterone receptor. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 4722-4726
204. Ucker D.S., Obermiller P.S., Eckhart W., Apgar J.R., Berger N.A., and Meyers J. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T-lymphocytes. Mol. Cell. Biol. 12 (1992) 3060-3069
205. Van Holde K.E. Chromain (1988), Springer Verlag, New York
206. van Steensel B., Jenster G., Damm K., Brinkmann A.O., and van Driel R. Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J. Cell. Biochem. 57 (1995) 465-478
207. van Wijnen A.J., Bidwell J.P., Fey E.G., Penman S., Lian J.B., Stein J.L., and Stein G.S. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry 32 (1993) 8397-8402
208. Verheijen R., van Venrooij W., and Ramaekers F. The nuclear matrix: Structure and composition. J. Cell Sci. 90 (1988) 11-36
209. Verrier C.S., Bailey L.R., Yee C.J., Roodi N., Jensen R.A., Bustin M., and Parl F.F. The interaction of the estrogen receptor with its DNA response element is facilitated by the high mobility group protein, HMG-1. Protein Eng. 8 (1995) 78
210. II30 affect estrogen receptor-mediated transcriptional activation. Mol. Endocrinol. 11 (1997) 1009-1019
211. vom Baur E., Zechel C., Heery D., Heine M.J., Garnier J.M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., and Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15 (1996) 110-124
212. Walker G., Pfeilschifter J., and Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone: Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J. Biol. Chem. 272 (1997) 16670-16687
213. Weaver V.M., Carson C.E., Walker P.R., Chaley N., Lach B., Raymond Y., Brown D.L., and Sikorska M. Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J. Cell Sci. 109 (1996) 45-56
214. Weis K.S., Rambaud S., Lavau C., Jansen J., Carvalho M., Carmo-Fonseca M., Lamond A.I., and Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell (Cambridge, Mass. 76 (1994) 345-356
215. Winston F., and Carlson M. Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 8 (1992) 387-391
216. Yamamoto K.R. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19 (1985) 209-252
217. Yang X.J., Ogryzki V.V., Nishikawa J., Howard B.H., and Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (London 382 (1996) 319-324
218. Yoshinaga S.K., Peterson C.L., Herskowitz I., and Yamamoto K.R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258 (1992) 1598-1604
219. Zambetti G., Ramsey-Ewing A., Bortell R., Stein G., and Stein J. Disruption of the cytoskeleton with cytochalasin D induces c-fos gene expression. Exp. Cell Res. 192 (1991) 93-101
220. Zeng C., He D., and Brinkley B.R. Localization of NuMA protein isoforms in the nuclear matrix of mammalian cells. Cell. Motil. Cytoskel. 29 (1994) 167-176
221. Zeng C., van Wijnen A.J., Stein J.L., Meyers S., Sun W., Shopland L., Lawrence J.B., Penman S., Lian J.B., Stein G.S., and Hiebert S.W. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-α transcription factors. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6746-6751
222. Zhuang Y.-H., Landers J.P., Schuchard M.D., Syvala H., Gosse B., Ruesnik T., and Tuohimaa P. Immunohistochemical localization of the avian progesterone receptor and its candidate acceptor protein, RBF-1. J. Cell Biochem. 54 (1993) 1-11